Montero-Melendez T - Search Results

1

Pro-resolving and anti-arthritic properties of the MC₁ selective agonist PL8177.

Garrido-Mesa J, Thomas BL, Dodd J, Spana C, Perretti M, Montero-Melendez T. Garrido-Mesa J, et al. Among authors: montero melendez t. Front Immunol. 2022 Nov 24;13:1078678. doi: 10.3389/fimmu.2022.1078678. eCollection 2022. Front Immunol. 2022. PMID: 36505403 Free PMC article.

2

Downstream gene activation of the receptor ALX by the agonist annexin A1.

Renshaw D, Montero-Melendez T, Dalli J, Kamal A, Brancaleone V, D'Acquisto F, Cirino G, Perretti M. Renshaw D, et al. PLoS One. 2010 Sep 17;5(9):e12771. doi: 10.1371/journal.pone.0012771. PLoS One. 2010. PMID: 20862244 Free PMC article.

3

Role of melanocortin receptors in the regulation of gouty inflammation.

Montero-Melendez T, Patel HB, Perretti M. Montero-Melendez T, et al. Curr Rheumatol Rep. 2011 Apr;13(2):138-45. doi: 10.1007/s11926-011-0163-0. Curr Rheumatol Rep. 2011. PMID: 21243457 Review.

4

The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties.

Montero-Melendez T, Patel HB, Seed M, Nielsen S, Jonassen TE, Perretti M. Montero-Melendez T, et al. Am J Pathol. 2011 Jul;179(1):259-69. doi: 10.1016/j.ajpath.2011.03.042. Epub 2011 May 10. Am J Pathol. 2011. PMID: 21703408 Free PMC article.

5

Molecular engineering of short half-life small peptides (VIP, αMSH and γ₃MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics.

Vessillier S, Adams G, Montero-Melendez T, Jones R, Seed M, Perretti M, Chernajovsky Y. Vessillier S, et al. Ann Rheum Dis. 2012 Jan;71(1):143-9. doi: 10.1136/annrheumdis-2011-200100. Epub 2011 Oct 13. Ann Rheum Dis. 2012. PMID: 21998117

6

Annexin A1 N-terminal derived Peptide ac2-26 exerts chemokinetic effects on human neutrophils.

Dalli J, Montero-Melendez T, McArthur S, Perretti M. Dalli J, et al. Front Pharmacol. 2012 Feb 28;3:28. doi: 10.3389/fphar.2012.00028. eCollection 2012. Front Pharmacol. 2012. PMID: 22403546 Free PMC article.

7

Melanocortin receptors as novel effectors of macrophage responses in inflammation.

Patel HB, Montero-Melendez T, Greco KV, Perretti M. Patel HB, et al. Front Immunol. 2011 Sep 13;2:41. doi: 10.3389/fimmu.2011.00041. eCollection 2011. Front Immunol. 2011. PMID: 22566831 Free PMC article.

8

Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells.

Schutters K, Kusters DH, Chatrou ML, Montero-Melendez T, Donners M, Deckers NM, Krysko DV, Vandenabeele P, Perretti M, Schurgers LJ, Reutelingsperger CP. Schutters K, et al. Cell Death Differ. 2013 Jan;20(1):49-56. doi: 10.1038/cdd.2012.107. Epub 2012 Sep 7. Cell Death Differ. 2013. PMID: 22955945 Free PMC article.

9

Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors.

Montero-Melendez T, Dalli J, Perretti M. Montero-Melendez T, et al. Cell Death Differ. 2013 Apr;20(4):567-75. doi: 10.1038/cdd.2012.154. Epub 2012 Dec 7. Cell Death Differ. 2013. PMID: 23222458 Free PMC article.

10

The calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritis.

Al-Kashi A, Montero-Melendez T, Moradi-Bidhendi N, Gilligan JP, Mehta N, Perretti M. Al-Kashi A, et al. PLoS One. 2013;8(2):e54299. doi: 10.1371/journal.pone.0054299. Epub 2013 Feb 5. PLoS One. 2013. PMID: 23393556 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters